Medtronic Spinal and Biologics
Clinical trials sponsored by Medtronic Spinal and Biologics, explained in plain language.
A division of Medtronic focused on spinal and biologic products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New bone graft study aims to improve spine surgery outcomes Results expected Jul 2027 (estimated)
-
New bone graft could improve spine surgery outcomes
Disease control OngoingThis study tests whether a special bone graft (Infuse Bone Graft with Mastergraft Strip) helps fuse multiple spine bones better than a standard graft in people with degenerative lower back conditions. About 100 adults will be randomly assigned to receive either the new graft or a…
Sponsor: Medtronic Spinal and Biologics • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New bone graft study aims to improve spine surgery outcomes
Disease control OngoingThis study tests whether a special bone graft (Infuse) helps spine bones fuse together better after back surgery. About 600 adults with degenerative spine disease will be followed for two years. The goal is to see if the graft reduces pain, improves function, and safely helps bon…
Sponsor: Medtronic Spinal and Biologics • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC